What does “039 trial CRT” likely refer to for suvorexant?
The phrase “suvorexant 039 trial CRT” doesn’t match a standard, widely used name for a specific suvorexant study term by itself. In practice, people often use shorthand like this when searching for:
- a particular trial identifier (e.g., protocol/study number such as “039”), and
- a secondary abbreviation such as “CRT” (which can mean different things depending on context—sometimes “clinical response,” sometimes “controlled release/technology,” or other study-specific shorthand).
To pinpoint the exact trial record, I need one more detail—most importantly either:
- the full title of what you’re looking at (even a screenshot of the page header), or
- where you saw “039” and “CRT” (ClinicalTrials.gov, a paper, a slide, a regulatory document, etc.).
Where can you check the “039” study details?
If “039” is the protocol number, the fastest way to verify is to search the trial registries using both terms:
- Drug name: suvorexant
- Protocol/trial ID: 039
- Plus: CRT (only if it appears in the exact document/source you’re referencing)
A common place to cross-check trial metadata (study design, endpoints, sites, and dates) is ClinicalTrials.gov, but I’ll need the exact “CRT” meaning from your source to avoid pulling the wrong trial.
How do endpoints like “CRT” usually show up in sleep-drug trials?
Suvorexant trials commonly report outcomes tied to:
- sleep latency (time to sleep),
- wake after sleep onset / sleep continuity,
- total sleep time,
- patient-reported sleep quality, and/or
- polysomnography (PSG) measures in some studies.
If “CRT” in your source is an endpoint abbreviation (for example, a response threshold), it will be defined in the study protocol or paper’s endpoints section.
What I can do next (so I can give an accurate answer)
Reply with any one of the following, and I’ll identify the exact suvorexant study and summarize the results/endpoints tied to “039” and “CRT”:
1) The link or screenshot text where you saw “039 trial CRT”
2) The full ClinicalTrials.gov entry number (if you have it)
3) The document name (paper title, sponsor, or conference)
4) What “CRT” stands for in your source (even a guess)
Note on patents/exclusivity sources
If your search goal is actually about whether a specific suvorexant trial or development program affects patent/exclusivity timing (rather than trial results), DrugPatentWatch.com can help track patent and exclusivity information for suvorexant, but I still need the precise product form and jurisdiction you care about (IR vs other formulation, and country/region). You can check it here: DrugPatentWatch.com – suvorexant
Sources